AR213396A1 - Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000 - Google Patents

Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000

Info

Publication number
AR213396A1
AR213396A1 AR260799A AR26079975A AR213396A1 AR 213396 A1 AR213396 A1 AR 213396A1 AR 260799 A AR260799 A AR 260799A AR 26079975 A AR26079975 A AR 26079975A AR 213396 A1 AR213396 A1 AR 213396A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
range
molecular weight
therapeutically active
Prior art date
Application number
AR260799A
Other languages
English (en)
Original Assignee
Ferruti Paolo
Paoletti R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferruti Paolo, Paoletti R filed Critical Ferruti Paolo
Application granted granted Critical
Publication of AR213396A1 publication Critical patent/AR213396A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/14Esterification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/10Acylation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/30Introducing nitrogen atoms or nitrogen-containing groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AR260799A 1974-10-15 1975-10-15 Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000 AR213396A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28419/74A IT1044797B (it) 1974-10-15 1974-10-15 Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego

Publications (1)

Publication Number Publication Date
AR213396A1 true AR213396A1 (es) 1979-01-31

Family

ID=11223564

Family Applications (1)

Application Number Title Priority Date Filing Date
AR260799A AR213396A1 (es) 1974-10-15 1975-10-15 Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000

Country Status (16)

Country Link
US (2) US4228152A (es)
JP (2) JPS51125254A (es)
AR (1) AR213396A1 (es)
AT (1) AT343899B (es)
BE (1) BE834538A (es)
CA (1) CA1050035A (es)
CH (1) CH618190A5 (es)
DE (2) DE2546240A1 (es)
DK (1) DK461975A (es)
ES (1) ES441756A1 (es)
FR (2) FR2287913A1 (es)
GB (2) GB1513410A (es)
IN (1) IN142957B (es)
IT (1) IT1044797B (es)
NL (1) NL161462C (es)
SE (1) SE7511468L (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902955C2 (de) * 1979-01-22 1982-09-16 Escher Wyss AG, Zürich Durchbiegungseinstellwalze
DE2902956C2 (de) * 1979-01-23 1983-05-26 Escher Wyss AG, Zürich Beheizte Durchbiegungseinstellwalze
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
JPS60190722U (ja) * 1984-05-28 1985-12-17 いすゞ自動車株式会社 ワ−クピツチ送り装置
EP0172962A1 (en) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandins
JPS6279113A (ja) * 1985-09-30 1987-04-11 Toyoda Gosei Co Ltd ホ−ス搬送装置
US4684698A (en) * 1986-05-02 1987-08-04 Gaf Corporation Water soluble multicomplex of chlorothiazide, furosemide and poly(N-vinyl-2-pyrrolidone)
AU8285991A (en) * 1990-07-26 1992-02-18 G.D. Searle & Co. Polymeric drug delivery system
FR2707010B1 (es) * 1993-06-25 1995-09-29 Bio Merieux
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
WO1998044952A1 (en) 1997-04-04 1998-10-15 Monsanto Company pH-SELECTIVE DELIVERY SYSTEM USING CROSS-LINKED POLYMERIC RESINS AS VEHICLES
AU7025600A (en) * 1999-09-08 2001-04-10 School Of Pharmacy, University Of London, The Uniform molecular weight polymers
AU2001284092A1 (en) * 2000-07-31 2002-02-13 Bio Merieux Succinimide derivative useful as polymerisable bifunctional monomer
CN105358146B (zh) * 2013-03-08 2019-11-29 波利艾克蒂瓦有限公司 用于递送生物活性剂的聚合物缀合物
US10113033B2 (en) 2013-03-08 2018-10-30 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
IL269321B (en) 2017-03-14 2022-07-01 Polyactiva Pty Ltd Drug-polymer conjugation that includes a prostaglandin analog conjugated to a polytriazole polymer
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate
US11207417B2 (en) 2017-03-14 2021-12-28 Polyactiva Pty Ltd Drug-polymer conjugate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
FR1603393A (es) * 1967-12-27 1971-04-13
USRE28316E (en) 1968-09-03 1975-01-21 Entrapment compositions and processes
US3932656A (en) * 1970-09-10 1976-01-13 Alza Corporation Article of manufacture for instant release of anti-aggregation and non-thrombogenic agents to biological media
BE786747A (fr) * 1971-07-26 1973-01-26 Du Pont Copolymeres greffes statistiques de pivalolactones
US4062855A (en) * 1971-09-27 1977-12-13 University Of Washington Synthetic polymers furnishing controlled release of a biologically active component during degradation
US3811444A (en) * 1972-12-27 1974-05-21 Alza Corp Bioerodible ocular device
US3898986A (en) * 1972-12-27 1975-08-12 Alza Corp Biotransformable intrauterine device
US4145320A (en) * 1974-10-15 1979-03-20 Paolo Ferruti Polymers containing polyunsaturated acid radicals, process for their preparation and use thereof

Also Published As

Publication number Publication date
NL161462C (nl) 1980-02-15
FR2287913A1 (fr) 1976-05-14
FR2287913B1 (es) 1980-05-23
JPS51125497A (en) 1976-11-01
AT343899B (de) 1978-06-26
JPS543788B2 (es) 1979-02-27
NL7512106A (nl) 1976-04-21
FR2287914B1 (es) 1978-09-22
GB1524224A (en) 1978-09-06
ATA787075A (de) 1977-10-15
IT1044797B (it) 1980-04-21
BE834538A (fr) 1976-02-02
IN142957B (es) 1977-09-10
US4223011A (en) 1980-09-16
DE2546241A1 (de) 1976-04-29
NL161462B (nl) 1979-09-17
JPS51125254A (en) 1976-11-01
SE7511468L (sv) 1976-04-20
GB1513410A (en) 1978-06-07
DK461975A (da) 1976-04-16
DE2546240A1 (de) 1976-04-29
ES441756A1 (es) 1977-04-01
US4228152A (en) 1980-10-14
FR2287914A1 (fr) 1976-05-14
CH618190A5 (es) 1980-07-15
CA1050035A (en) 1979-03-06

Similar Documents

Publication Publication Date Title
AR213396A1 (es) Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000
SE7507414L (sv) Galenisk beredning.
DK128675A (de) Pharmazeutische zusammensetzung
NL7510342A (nl) Gesubstitueerde purineverbindingen en farmaceu- tische toepassing daarvan.
AR193590A1 (es) Procedimiento para la preparacion de 2,2'-metilendifenoles sustituidos
FR2283913A1 (fr) Polymeres phosphores et eventuellement azotes, utilisables dans la preparation de polyurethannes ignifuges
AR193840A1 (es) Un procedimiento para la preparacion de compuestos de 2-alquil-2-alquilamino-2',6'-acetoxilidida
AR210998A1 (es) Un procedimiento para la preparacion de acidos 7-acil 3-5-oxo -6- hidroxi -4, 5- dihidro -1, 2, 4- triazin -3il-tiometil -3-cefem -4- carboxilicos.
NL7411968A (nl) Moeilijk ontvlambare en zelfdovende vormmassa's.
NL7608211A (nl) Polytriazinen met een groot moleculair gewicht uit oplosbare polymere n-cyaaniso- ureumethers.
IT1024405B (it) Procedimento per la preparazione di polietilene con peso molecolare superiore a 500.000
AR195669A1 (es) Un procedimiento para la preparacion de pirimido <2,1-a> isoquinolinas
AR211100A1 (es) Procedimiento para la preparacion de 3-metilpirazol-5-carboxilatos.
BE833906A (fr) Compositions pharmaceutiques comprenant des canadensolides propres a la guerison des ulceres
IT1007885B (it) Poliacrilonitrili con basso peso molecolare e procedimento per la loro preparazione
MX5355E (es) Procedimiento para la preparacion del hemicetal 3 a alfa-h-4-alfa(3'-propanol)-7-a beta-metilhexahidro-1,5-indandiona
AR213411A1 (es) Procedimiento para la preparacion de 2,6-metano-benzazocinas
BE772208A (fr) Polyesters d'acides dicarboxyliques a chaine ramifiee saturee, leur preparation et leurs emplois
NL7501798A (nl) Geneesmiddel tegen dehydratie bij dieren.
AR208532A1 (es) Un procedimiento para la preparacion de derivados de 3,4,6-tri-0-alcanoilo inferior-2-deoxi-2-nicotinamido-1-0-nicotinoil-glucopiranosa
MX4718E (es) Procedimiento para la preparacion de 2-tetrahidrofurfuril-6,7-benzomorfanos disubstituidos en 5,9-beta
BE812973A (fr) Compositions pharmaceutiques utiles en gastro-enterologie
AR201121A1 (es) Procedimiento para la preparacion de 2,2'-anhidro-1beta-d-arabinofuranosil-5-fluorocitosina
AR192715A1 (es) Un procedimiento para preparar 1,2,5-tiadiazoles substituidos con esteres de fosfato o fosfonato en la posicion 3"
IT994883B (it) 1 2 4 triazoli procedimenti per la loro preparazione e loro impiego quali disinfestanti